COVID-19 Infection-Preventing Clinical Deterioration

JAMA. 2020 Dec 8;324(22):2300. doi: 10.1001/jama.2020.21720.

Authors

Christopher W Seymour^{1

2}, Howard Bauchner³, Robert M Golub⁴

Affiliations

¹ Associate Editor, JAMA.
² Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
³ Editor, JAMA.
⁴ Deputy Editor, JAMA.

PMID: 33180115
DOI: 10.1001/jama.2020.21720

No abstract available

Publication types

Comment

MeSH terms

COVID-19 Drug Treatment*
Clinical Deterioration*
Fluvoxamine
Humans
Outpatients
Pandemics
Pneumonia, Viral* / epidemiology
SARS-CoV-2

Substances

Fluvoxamine